Home
SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and linking to clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Help make cancer history
100% of your gift will support leading-edge cancer research, which will lead to better outcomes for patients with cancer, and their families.
With your support, we can save lives.
Featured projects
Towards the future: improving survivorship for children with brain cancer
Brain cancer is the most common solid tumour of childhood and most lethal type of cancer in Australian children.
Read more about improving survivorship for children with brain cancer
Unlocking the mysteries of prostate cancer
The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.
Read more about Unlocking the mysteries of prostate cancerLeadership appointments
Professor Christopher Sweeney
Professor Christopher Sweeney is SAiGENCI's inaugural Director.
Professor Lisa Butler
Professor Lisa Butler is the Lead SAiGENCI Associate in SAHMRI, and Prostate Cancer Theme Lead in the Hormone Dependent Cancers program. She also leads SAiGENCI’s Graduate Program for HDR and Honours students.
Professor Brendan Jenkins
Professor Brendan Jenkins is Program Lead for the Tumour Inflammation and Immunotherapy program.
Professor Jose Polo
Professor Jose Polo is Program Lead for Cancer Epigenetics in SAiGENCI, building the epigenetics capacity within the Institute. Professor Polo has established the Adelaide Centre for Epigenetics (ACE).
News
18 Jun
Movember and SAiGENCI partner on landmark database to drive improvements in prostate cancer care
Movember, the leading global men’s health charity, has partnered with the South Australian immunoGENomics Cancer Institute (SAiGENCI) at the University of Adelaide, to create a transformative database that will help researchers develop strategies for clinicians to personalise decisions about prostate cancer care. 29 May
SAiGENCI Annual Public Lecture - Decoding Cancer: How epigenetics could solve the cancer riddle
Held on Tuesday 21 May in the Braggs Lecture Theatre, the SAiGENCI Annual Public Lecture was a great success with 230 attending the live event and 50 viewing online.
Events
15 Feb
The Adelaide Cancer Seminar Series
The Adelaide Cancer Seminar Series are jointly organised by the South Australian immunoGENomics Cancer Institute (SAiGENCI), Centre for Cancer Biology (CCB) and the South Australian Health and Medical Research Institute (SAHMRI). The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists.
